Creo Medical
Generated by Meeveem AI
"Pioneering advanced energy medical devices for minimally invasive therapeutic endoscopy"
Chepstow
•51 - 250 Employees
•Medical Devices
About Creo Medical
Creo Medical develops advanced energy devices for minimally invasive endoscopic procedures. The company's Kamaptive Technology combines microwave and bipolar radiofrequency energy to power devices used in gastroenterology, urology and pulmonology. Clinicians use them to cut, coagulate and ablate tissue precisely, offering patients an alternative to major surgery with shorter recovery times. Founded in 2003 and listed on the London Stock Exchange, Creo Medical partners with healthcare providers globally. Their devices address unmet needs in colorectal lesion removal and early cancer treatment. NHS case studies show cost savings of over £687,000 across procedures, proving the value of their approach to both patients and healthcare systems.
115
Team Members
2003
Founded
Medical Devices
Sector
Hybrid
Work Environment
Our Vision
A world where complex conditions are treated through minimally invasive endoscopic procedures, sparing patients from major surgery and accelerating recovery across healthcare systems globally.
Our Mission
At Creo Medical, our mission is to transform patient lives by delivering pioneering endoscopic healthcare solutions to clinicians and healthcare providers across the world.